Article info
Inhaled therapy in COPD
P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study
Citation
P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study
Publication history
- First published November 14, 2013.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions